Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.3%
0%
14.3%
6 Months
7.65%
0%
7.65%
1 Year
32.86%
0%
32.86%
2 Years
64.64%
0%
64.64%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Zhejiang Haisen Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.10%
EBIT Growth (5y)
10.18%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
0.33
Tax Ratio
13.44%
Dividend Payout Ratio
9.43%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
32.05%
ROE (avg)
8.77%
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
2.54
EV to EBIT
20.54
EV to EBITDA
17.84
EV to Capital Employed
5.71
EV to Sales
5.24
PEG Ratio
NA
Dividend Yield
0.05%
ROCE (Latest)
27.79%
ROE (Latest)
8.96%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
173.40
151.50
14.46%
Operating Profit (PBDIT) excl Other Income
55.60
36.80
51.09%
Interest
0.10
0.10
Exceptional Items
1.70
0.00
Consolidate Net Profit
47.70
35.60
33.99%
Operating Profit Margin (Excl OI)
280.20%
212.20%
6.80%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 14.46% vs 32.55% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 33.99% vs 8.87% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
529.70
468.30
13.11%
Operating Profit (PBDIT) excl Other Income
166.30
133.70
24.38%
Interest
0.60
0.60
Exceptional Items
1.80
0.00
Consolidate Net Profit
135.90
122.60
10.85%
Operating Profit Margin (Excl OI)
269.20%
249.20%
2.00%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 13.11% vs 18.74% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 10.85% vs 17.10% in Dec 2024
About Zhejiang Haisen Pharmaceutical Co., Ltd. 
Zhejiang Haisen Pharmaceutical Co., Ltd.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






